Delisting riskPopularity #5,405
Bon Natural Life (BON)
Plant-derived fragrance, food-ingredient, and health-supplement supplier.
$1.20
After hours−0.01 (−0.83%)
At close$1.21(+0.17%)
In millions of USD, except per-share figures
| In millions | Q2 FY20Mar 2020 | Q4 FY20Sep 2020 | Q2 FY21Mar 2021 | Q4 FY21Sep 2021 | Q2 FY22Mar 2022 | Q4 FY22Sep 2022 | Q2 FY23Mar 2023 | Q4 FY23Sep 2023 | Q2 FY24Mar 2024 | Q4 FY24Sep 2024 | Q2 FY25Mar 2025 | Q4 FY25Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7 | 11 | 12 | 14 | 14 | 16 | 14 | 15 | 10 | 14 | 8 | 11 |
| Cost of revenue | 5 | 8 | 8 | 10 | 10 | 11 | 9 | 11 | 7 | 10 | 6 | 9 |
| Gross profit | 3 | 3 | 3 | 4 | 4 | 5 | 5 | 4 | 3 | 4 | 2 | 2 |
| 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 3 | 2 | 2 | 4 | |
| Research & development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 |
| Selling, general & administrative | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 2 | 2 | 3 |
| Operating income | 2 | 2 | 3 | 3 | 3 | 4 | 3 | 3 | 0 | 2 | 0 | −2 |
| 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | −1 | 0 | 0 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | 0 | — |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | 0 | 0 | 0 | 0 | −1 | −1 | 0 | 0 | 0 | 1 | 0 | 0 |
| Income before tax | 2 | 2 | 3 | 3 | 3 | 4 | 3 | 3 | 0 | 1 | 0 | −2 |
| Income tax expense | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | 2 | 2 | 2 | 2 | 3 | 4 | 2 | 2 | 0 | 0 | 0 | −2 |
| Discontinued operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | 2 | 1 | 2 | 2 | 3 | 4 | 2 | 2 | 0 | 0 | 0 | −2 |
| EPS, basic | $2.97 | $2.83 | $3.99 | $2.94 | $3.00 | $4.40 | $2.38 | $2.60 | −$0.01 | $0.23 | $0.56 | −$0.79 |
| EPS, diluted | $2.97 | $2.84 | $3.99 | $2.99 | $3.04 | $4.39 | $2.36 | $2.60 | −$0.01 | $0.22 | $0.50 | −$0.79 |
| Weighted average shares, basic | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 0 | 3 |
| Weighted average shares, diluted | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 0 | 3 |
| EBITDA | 2 | 2 | 3 | 3 | 4 | 5 | 3 | 4 | 1 | 1 | 1 | −1 |
| Depreciation & amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 |
| EBIT | 2 | 2 | 3 | 3 | 3 | 5 | 3 | 3 | 0 | 1 | 0 | −2 |